These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7487091

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne.
    Roberts ES, Alworth WL, Hollenberg PF.
    Arch Biochem Biophys; 1998 Jun 15; 354(2):295-302. PubMed ID: 9637739
    [Abstract] [Full Text] [Related]

  • 24. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
    Lin HL, Kent UM, Hollenberg PF.
    J Pharmacol Exp Ther; 2005 Apr 15; 313(1):154-64. PubMed ID: 15608076
    [Abstract] [Full Text] [Related]

  • 25. Mechanism-based inhibition of mouse P4502b-10 by selected arylalkynes.
    Beebe LE, Roberts ES, Fornwald LW, Hollenberg PF, Alworth WL.
    Biochem Pharmacol; 1996 Nov 22; 52(10):1507-13. PubMed ID: 8937464
    [Abstract] [Full Text] [Related]

  • 26. Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid.
    López-Garcia MP, Dansette PM, Mansuy D.
    Biochemistry; 1994 Jan 11; 33(1):166-75. PubMed ID: 8286335
    [Abstract] [Full Text] [Related]

  • 27. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL, Peter RM, Thompson SJ, Rettie AE, Trager WF.
    Drug Metab Dispos; 1997 Dec 11; 25(12):1407-15. PubMed ID: 9394031
    [Abstract] [Full Text] [Related]

  • 28. Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394.
    Lightning LK, Jones JP, Friedberg T, Pritchard MP, Shou M, Rushmore TH, Trager WF.
    Biochemistry; 2000 Apr 18; 39(15):4276-87. PubMed ID: 10757976
    [Abstract] [Full Text] [Related]

  • 29. Mechanism-based inactivation of cytochrome P450 2B1 by 7-ethynylcoumarin: verification of apo-P450 adduction by electrospray ion trap mass spectrometry.
    Regal KA, Schrag ML, Kent UM, Wienkers LC, Hollenberg PF.
    Chem Res Toxicol; 2000 Apr 18; 13(4):262-70. PubMed ID: 10775326
    [Abstract] [Full Text] [Related]

  • 30. Interaction between cytochrome P450 2B1 and cytochrome bs: inhibition by synthetic peptides indicates a role for P450 residues Lys-122 and Arg-125.
    Omata Y, Sakamoto H, Robinson RC, Pincus MR, Friedman FK.
    Biochem Biophys Res Commun; 1994 Jun 30; 201(3):1090-5. PubMed ID: 8024550
    [Abstract] [Full Text] [Related]

  • 31. The mechanism of stimulation of NADPH oxidation during the mechanism-based inactivation of cytochrome P450 2B1 by N-methylcarbazole: redox cycling and DNA scission.
    Shen T, Hollenberg PF.
    Chem Res Toxicol; 1994 Jun 30; 7(2):231-8. PubMed ID: 8199313
    [Abstract] [Full Text] [Related]

  • 32. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
    Mikalsen A, Alexander J, Wallin H, Ingelman-Sundberg M, Andersen RA.
    Carcinogenesis; 1991 May 30; 12(5):825-31. PubMed ID: 1903091
    [Abstract] [Full Text] [Related]

  • 33. Production of a form-specific, inhibitory antibody against rat cytochrome P450 2B1 using a synthetic peptide antigen against a putative substrate binding site.
    Charnecki J, Putt D, Kim EY, Kim H.
    Biochem Biophys Res Commun; 1995 Nov 22; 216(3):1024-33. PubMed ID: 7488175
    [Abstract] [Full Text] [Related]

  • 34. Inductive effect of Telazol on hepatic expression of cytochrome P450 2B in rats.
    Wong A, Bandiera SM.
    Biochem Pharmacol; 1996 Sep 13; 52(5):735-42. PubMed ID: 8765471
    [Abstract] [Full Text] [Related]

  • 35. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
    Butler AM, Murray M.
    Mol Pharmacol; 1993 Jun 13; 43(6):902-8. PubMed ID: 8316222
    [Abstract] [Full Text] [Related]

  • 36. Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase.
    Shen S, Strobel HW.
    Arch Biochem Biophys; 1993 Jul 13; 304(1):257-65. PubMed ID: 8323289
    [Abstract] [Full Text] [Related]

  • 37. Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9.
    Koenigs LL, Peter RM, Hunter AP, Haining RL, Rettie AE, Friedberg T, Pritchard MP, Shou M, Rushmore TH, Trager WF.
    Biochemistry; 1999 Feb 23; 38(8):2312-9. PubMed ID: 10029524
    [Abstract] [Full Text] [Related]

  • 38. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
    Grimm SW, Dyroff MC, Philpot RM, Halpert JR.
    Mol Pharmacol; 1994 Dec 23; 46(6):1090-9. PubMed ID: 7808429
    [Abstract] [Full Text] [Related]

  • 39. Denaturation of cytochrome P450 2B1 by guanidine hydrochloride and urea: evidence for a metastable intermediate state of the active site.
    Yu XC, Shen S, Strobel HW.
    Biochemistry; 1995 Apr 25; 34(16):5511-7. PubMed ID: 7727410
    [Abstract] [Full Text] [Related]

  • 40. Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices.
    Poet TS, Brendel K, Halpert JR.
    Toxicol Appl Pharmacol; 1994 May 25; 126(1):26-32. PubMed ID: 8184429
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.